filmov
tv
Crispr Therapeutics CEO: Science in gene editing is moving at break-neck speed
Показать описание
Samarth Kulkarni, Crispr Therapeutics CEO, joins 'Power Lunch' to discuss the hurdles to getting rare disease drugs through regulation, what consumers can look forward to in gene editing, and much more.
Crispr Therapeutics CEO: Science in gene editing is moving at break-neck speed
Samarth Kulkarni, CEO, CRISPR Therapeutics
Who is CRISPR Therapeutics?
CRISPR's Next Advance Is Bigger Than You Think | Jennifer Doudna | TED
Day 2: Gene Editing and CRISPR
CRISPR Therapeutics
CRISPR Therapeutics - Allogeneic Cell Therapies
Opening Remark: How CRISPR Impacts The Biotech Industry
Gene editing through CRISPR will have great benefits to health and the environment
The Future of Healthcare // The Unknown and What’s Possible
The promise of CRISPR genome editing in human health #shorts #podcast #crispr #genomeediting
Companies Racing to Use Crispr to Fight Disease
AAAS Science Matters: CRISPR Gene Editing
CRISPR THERAPEUTICS AG (NASDAQ: CRSP) CEO INTERVIEW ON GENE THERAPY, BUSINESS AND GROWTH - PART 1
Researchers Develop a CRISPR-Based Therapy That Penetrates Solid Tumors
Gene Editing Inside the Body Using CRISPR
Breakthrough Economy: Cell and Gene Therapy Innovations
CRISPR Therapeutics Stock: Fundamental Analysis 2021 (+ overlooked news)
The Age of CRISPR: Engineering the Future of Genetic Medicine | Benjamin Oakes | TEDxBerkeley
CRISPR Science and Stocks: Knowing Enough to Invest
Intellia and the #NewEraOfMedicine (in vivo CRISPR)
The World’s First CRISPR-Based Therapeutic Approval #shorts #CRISPR
CRISPR Gene editing in 60 seconds / Explained by Nobel prize winner Jennifer Doudna (Part 1) #shorts
Nobel winners Doudna, Charpentier discover how CRISPR Cas9 gene editing works | Good Chemistry
Комментарии